Drug Trial Radar · NCT03345979
A Study of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia
Last checked: Nov 20, 2026Latest source record: Aug 11, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
200
Actual
Start
Nov 15, 2017
Primary completion
Mar 12, 2019
Study completion Mar 12, 2019
Sponsor
- Lead sponsor
- Alkermes, Inc.Industry
- Sponsor type
- Industry
- First posted
- Nov 17, 2017
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study will evaluate the efficacy of initiating treatment of schizophrenia with ARISTADA INITIO plus 30 mg oral aripiprazole followed by a 2-month dose of AL.
Conditions
- Schizophrenia
Interventions
Aripiprazole LauroxilCombination product
Intramuscular injection; study drug provided using a pre-filled syringe
Paliperidone PalmitateDrug
Intramuscular injection
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline in the Positive and Negative Syndrome Scale (PANSS) Total Score at Week 4Time frame: Baseline and 4 weeks
Locations
16 sites in 1 country. Site status is shown where the registry gives one.
Alkermes Investigational Site
Little Rock, Arkansas
Alkermes Investigational Site
Rogers, Arkansas
Alkermes Investigational Site
Cerritos, California
Alkermes Investigational Site
Culver City, California
Alkermes Investigational Site
Garden Grove, California
Alkermes Investigational Site
Lemon Grove, California
Alkermes Investigational Site
Hialeah, Florida
Alkermes Investigational Site
Chicago, Illinois
Alkermes Investigational Site
Hoffman Estates, Illinois
Alkermes Investigational Site
Flowood, Mississippi
Alkermes Investigational Site
St Louis, Missouri
Alkermes Investigational Site
Las Vegas, Nevada
Alkermes Investigational Site
Berlin, New Jersey
Alkermes Investigational Site
Austin, Texas
Alkermes Investigational Site
Garland, Texas
Alkermes Investigational Site
Richardson, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.